scholarly journals 712P Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial

2020 ◽  
Vol 31 ◽  
pp. S560-S561
Author(s):  
J. Courcier ◽  
C. Dalban ◽  
B. Laguerre ◽  
S. Ladoire ◽  
P. Barthélémy ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Primary Tumour ◽  
Tumour Response

scholarly journals Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment

2022 ◽  
Vol 35 ◽  
pp. 54-58
Author(s):  
Aafke Meerveld-Eggink ◽  
Niels Graafland ◽  
Sofie Wilgenhof ◽  
Johannes V. Van Thienen ◽  
Ferry Lalezari ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Real World ◽  
Renal Cell ◽  
Tumour Response ◽  
Renal Tumour ◽  
Real World Data ◽  
World Data ◽  
Data Assessment

scholarly journals 737P Synchronous metastatic renal cell carcinoma (mRCC) treated with nivolumab and ipilimumab (N+I) and the primary tumour (PT) in place

2020 ◽  
Vol 31 ◽  
pp. S575
Author(s):  
A. Meerveld-Eggink ◽  
N. Graafland ◽  
S. Wilgenhof ◽  
J.V. van Thienen ◽  
M. Grant ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Primary Tumour

scholarly journals Metastatic renal cell carcinoma to the thyroid gland 24 years after the primary tumour

2013 ◽  
Vol 2013 (jan25 1) ◽  
pp. bcr2012007569-bcr2012007569 ◽  
Author(s):  
V. Di Stasi ◽  
A. D'Antonio ◽  
A. Caleo ◽  
L. Valvano
Keyword(s):  
Renal Cell Carcinoma ◽  
Thyroid Gland ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Primary Tumour
Sign in / Sign up

Export Citation Format

Share Document